Trials / Completed
CompletedNCT05242367
Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for PTSD
A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Electrical Vestibular Nerve Stimulation (VeNS), Compared to a Sham Control for Treatment of Post- Traumatic Stress Disorder (PTSD)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 383 (actual)
- Sponsor
- Neurovalens Ltd. · Industry
- Sex
- All
- Age
- 22 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Trial title: A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Electrical Vestibular Nerve Stimulation (VeNS), Compared to a Sham Control for Treatment of PTSD The aim of this study: To better evaluate the efficacy of non-invasive electrical vestibular nerve stimulation (VeNS) as a method of treating PTSD, as compared to a sham control. Allocation: Randomized to either active device or control device usage. Endpoint classification: Efficacy Study Intervention Model: Parallel Assignment in 1:1 active to control allocation Sample size: The aim is to recruit a total of up to 400 participants. The study will last 12 weeks in total for each subject.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Modius Spero active device | Battery powered non-invasive neurostimulation device |
| DEVICE | Sham device | Placebo comparator sham device (no active stimulation) |
Timeline
- Start date
- 2023-02-13
- Primary completion
- 2024-12-02
- Completion
- 2024-12-02
- First posted
- 2022-02-16
- Last updated
- 2025-06-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05242367. Inclusion in this directory is not an endorsement.